Asia Pacific Point-of-Care Molecular Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product & Services (Assays & Kits, Instruments, and Services & Software), Technology [PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies], Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

No. of Pages: 208    |    Report Code: TIPRE00026189    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Point-of-Care Molecular Diagnostics Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2        Asia Pacific Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3        Asia Pacific Point-of-Care Molecular Diagnostics Market – By Application

1.3.4        Asia Pacific Point-of-Care Molecular Diagnostics Market – By End User

1.3.5        Asia Pacific Point-of-Care Molecular Diagnostics Market– By Geography

2.           Asia Pacific Point-of-Care Molecular Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Experts Opinion

5.           Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2        Rising Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        Pricing Pressures owing to Reimbursement Cuts

5.3         Market Opportunities

5.3.1        Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4         Future Trends

5.4.1        Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5         Impact Analysis

6.           Point-of-Care Molecular Diagnostics Market– Asia Pacific Analysis

6.1         Asia Pacific Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7.           Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & Services

7.1         Overview

7.2         Point-of-Care Molecular Diagnostics Market, by Product & Services 2021 & 2028 (%)

7.3         Assays and Kits

7.3.1        Overview

7.3.2        Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Services and Software

7.5.1        Overview

7.5.2        Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1         Overview

8.2         Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)

8.3         PCR

8.3.1        Overview

8.3.2        PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1        Overview

8.4.2        Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1         Overview

9.2         Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)

9.3         Infectious Disease

9.3.1        Overview

9.3.2        Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Oncology

9.4.1        Overview

9.4.2        Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Hematology

9.5.1        Overview

9.5.2        Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Prenatal Testing

9.6.1        Overview

9.6.2        Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Endocrinology

9.7.1        Overview

9.7.2        Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1      Overview

10.2      Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Diagnostic Laboratories

10.4.1     Overview

10.4.2     Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Research and Academic Institutes

10.5.1     Overview

10.5.2     Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        Asia Pacific Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1      Asia Pacific: Point-of-Care Molecular Diagnostics Market

11.1.1     Overview

11.1.2     Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

11.1.3     Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.4     Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.5     Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.6     Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7     Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

11.1.7.1       China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.1       China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.2       China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3       China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4       China: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.1.5       China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.2       Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.1       Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.2       Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3       Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4       Japan: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.2.5       Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.3       India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.1       India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.2       India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3       India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4       India: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.3.5       India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.4       Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.4.1       Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.4.2       Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.4.3       Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.4.4       Australia: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.4.5       Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.5       South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.5.1       South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.5.2       South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.5.3       South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.5.4       South Korea: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.5.5       South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.6       Thailand: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.6.1       Thailand: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.6.2       Thailand: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.6.3       Thailand Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.6.4       Thailand: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.6.5       Thailand Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.7       Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.7.1       Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.7.2       Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

11.1.7.7.3       Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.7.4       Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

11.1.7.7.5       Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

13.        Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3      Organic Growth Strategies

13.3.1     Overview

13.4      Inorganic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      F. Hoffmann-La Roche Ltd.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      bioMérieux SA

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Abbott

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      MERIDIAN BIOSCIENCE, INC.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Enzo Biochem Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Biocartis

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Quidel Corporation

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Danaher

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      BIO-RAD LABORATORIES INC.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 2.             Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 3.             Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 6.             China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7.             China: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 14.          India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15.          India: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 18.          Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 19.          Australia: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 22.          South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 23.          South Korea: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24.          South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          Thailand: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 26.          Thailand Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 27.          Thailand: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 28.          Thailand Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 33.          Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 34.          Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 35.          Glossary of Terms, Point-of-Care Molecular Diagnostics Market

 

 

LIST OF FIGURES

Figure 1.           Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2.           Asia Pacific Point-of-Care Molecular Diagnostics Market Overview

Figure 3.           Assays and Kits Segment Held the Largest Share by Product & Services in Asia Pacific Point-of-Care Molecular Diagnostics Market

Figure 4.           India to Show Significant Growth During Forecast Period

Figure 5.           Asia Pacific Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6.           Asia Pacific Point-of-Care Molecular Diagnostics Market- Leading Country Markets (US$ Million)

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Asia Pacific Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2021- 2028

Figure 9.           Point-of-Care Molecular Diagnostics Market, by Product & Services 2021 & 2028 (%)

Figure 10.        Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)

Figure 14.        PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)

Figure 18.        Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)

Figure 25.        Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 30.        Asia Pacific: Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 31.        Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 32.        China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Thailand: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Asia Pacific

Figure 40.          Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

The List of Companies - Asia Pacific Point-of-Care Molecular Diagnostics Market

  1. bioMérieux SA
  2.  F. Hoffmann-La Roche Ltd.
  3. Danaher Corporation
  4.  Enzo Biochem, Inc.
  5. Abbott
  6. binx health, Inc.
  7. Meridian BioScience, Inc.
  8. Biocartis
  9. Quidel Corporation
  10. Bio-Rad Laboratories, Inc.